INS and metabolic disease: Depletion of CRIg+ cells results in the spread of mEVs into distant metabolic tissues, subsequently exacerbating tissue inflammation and metabolic disorders; treatment of obese mEVs directly triggers inflammation and insulin resistance of hepatocytes and adipocytes.